Drug Profile
Temozolomide wafer - Medisun Precision Medicine
Alternative Names: ACX-31 - Medisun Precision Medicine; ACX-31 wafer - Medisun Precision MedicineLatest Information Update: 21 Sep 2023
Price :
$50
*
At a glance
- Originator Accelerating Combination Therapies
- Developer Accelerating Combination Therapies; Kintara Therapeutics; Medisun Precision Medicine
- Class 2 ring heterocyclic compounds; Amides; Epoxy compounds; Ethylene glycols; Imidazoles; Small molecules; Triazenes
- Mechanism of Action Alkylating agents; DNA cross linking agents; DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Brain cancer; Solid tumours
Most Recent Events
- 21 Sep 2023 Discontinued - Preclinical for Brain cancer in USA (Intracerebral)
- 21 Sep 2023 Discontinued for Solid tumours in USA (Intracerebral)
- 28 Oct 2020 No recent reports of development identified for preclinical development in Brain-cancer in USA (Intracerebral)